return to press releases

May 16, 2002

AnVil and ClinQuest Announce Marketing Partnership

Life sciences discovery pioneer and healthcare product-development solutions leader to team up for business development expansion efforts

Burlington, MA and Marlborough, MA - May 16, 2002 - As part of their continuing strategy to grow their business development networks, life sciences discovery pioneer AnVil and healthcare product-development solutions leader ClinQuest announced today a wide-reaching partnership that calls for both companies to refer each other's services and expertise to their respective client bases, offering life sciences companies the best match of skills, resources and experts to fulfill their scientific objectives.

The agreement calls for ClinQuest to refer AnVil to clients who require high-dimensional analysis, visualization and interpretation of large and multiple data sets. ClinQuest will also present AnVil as a ClinShareSM Partner, one of its key allies in a broad network of expert consultants. For its part, AnVil will refer clients to ClinQuest for healthcare product development services, such as strategic product development, clinical trial implementation, regulatory affairs consulting, and market research. Both companies will also call on each other's expertise and services to fulfill internal requirements and capabilities.

"We feel that partnering with ClinQuest is a clearly unique opportunity to mutually broaden our offerings to our clients," said Dr. Richard D. Gill, President and CEO of AnVil. "Together we can offer a wide spectrum of domain knowledge, giving clients an integrated team of complementary talents and capabilities to choose from."

"We are looking forward to collaborating with AnVil's team of experts," said Dr. Cornelis H. Wortel, President and CEO of ClinQuest. "AnVil's 'in silico' drug discovery and development solutions are a powerful addition to ClinQuest's comprehensive healthcare product development tools, which we provide to our clients to help bring their products from early pre-clinical stage through clinical development and market approval."

About ClinQuest, Inc.
ClinQuest, Inc., is a Healthcare Product Development Organization (PDO) that provides strategic product-development consulting and implementation to biotechnology, pharmaceutical, medical device and medical diagnostic companies. ClinQuest is a recognized leader in the development of new, break-through technologies and implementation and management of First-in-Man and very complex clinical studies. ClinQuest' team of industry experts and broad array of specialized services help the aforementioned industry clients cut the time to market, avert or overcome unforeseen challenges, break into new markets, and lower the true total cost of development by providing the expertise the clients need, where and when they need it.

ClinQuest is based in Marlborough, Massachusetts, a suburb of Boston. For more information visit www.clinquestinc.com, or call 508-486-9500. E-mail inquiries should be sent to: dpassov@clinquestinc.com

About AnVil
AnVil is a pioneering life sciences discovery company that turns data into knowledge. AnVil partners with life sciences, pharmaceutical, biotechnology, and healthcare companies, enabling them to see and interpret multiple data sets in integrated, information-rich views. This approach turns data into decision-quality information, generating informed decisions faster and more accurately. AnVil's combination of scientific perspective, expertise and high-dimensional technology uncovers the limitless possibilities within complex data sets.

AnVil is based in Burlington, Massachusetts. For more information, visit www.anvilinfo.com, or call 1-781-272-1600. E-mail inquiries should be sent to: William Wiegler at wwiegler@anvilinfo.com.

Copyright © 2002 AnVil, Inc. All rights reserved.

back to top